Baiyunshan said at the 2026 semi-annual results briefing held on September 14 that at present, the company has built more than 100 pipeline projects and connected and investigated nearly 50 BD innovative drug projects. Of these, more than 10 innovative drug pipeline introduction projects have been completed, and the treatment field covers many key clinical demand directions and cutting-edge fields. The company will continue to actively promote related BD work and fulfill disclosure obligations in a timely manner.

Baiyunshan said at the 2026 semi-annual results briefing held on September 14 that at present, the company has built more than 100 pipeline projects and connected and investigated nearly 50 BD innovative drug projects. Of these, more than 10 innovative drug pipeline introduction projects have been completed, and the treatment field covers many key clinical demand directions and cutting-edge fields. The company will continue to actively promote related BD work and fulfill disclosure obligations in a timely manner.